ArticlePloS one2023

Early changes in immunoglobulin G levels during immune checkpoint inhibitor treatment are associated with survival in hepatocellular carcinoma patients.

Lorenz Balcar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.